AI Verdict
MTRN has stronger fundamentals based on our AI analysis.
MTRN vs MTNB Fundamental Comparison
| Metric | MTRN | MTNB |
|---|---|---|
| Revenue | $1.8B | $1.1M |
| Net Income | $74.8M | $-10.3M |
| Net Margin | 4.2% | -943.9% |
| ROE | 7.9% | -214.2% |
| ROA | 4.2% | -143.5% |
| Current Ratio | 3.11x | 2.79x |
| Debt/Equity | 0.49x | 0.00x |
| EPS | $3.58 | $-2.00 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
MTRN vs MTNB: Frequently Asked Questions
Is MTRN or MTNB a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MTRN has stronger fundamentals. MTRN is rated BUY (72% confidence) while MTNB is rated STRONG SELL (92% confidence). This is not investment advice.
How does MTRN compare to MTNB fundamentally?
MATERION Corp has ROE of 7.9% vs Matinas BioPharma Holdings, Inc.'s -214.2%. Net margins are 4.2% vs -943.9% respectively.
Which stock pays higher dividends, MTRN or MTNB?
MTRN has a dividend yield of N/A or no dividend while MTNB has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in MTRN or MTNB for long term?
For long-term investing, consider that MTRN has BUY rating with 72% confidence, while MTNB has STRONG SELL rating with 92% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about MTRN vs MTNB?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For MTRN vs MTNB, the AI consensus favors MTRN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.